Psychometric Properties of the Borderline Symptom List (BSL)Bohus M.a · Limberger M.F.a · Frank U.b · Chapman A.L.c · Kühler T.d · Stieglitz R.-D.e
aDepartment of Psychosomatics and Psychotherapy, Central Institute of Mental Health Mannheim, Mannheim, and bDepartment of Psychology, Albert Ludwig University Freiburg, Freiburg, Germany; cDepartment of Psychology, Simon Fraser University, Burnaby, B.C., Canada; dPsychiatric-Psychotherapeutic Hospital for Women Meissenberg, Zug, and eUniversity Psychiatric Outpatient Department, Basel, Switzerland
Prof. Dr. M. Bohus
Department of Psychosomatics and Psychotherapy
Central Institute of Mental Health, J 5
DE–68159 Mannheim (Germany)
Tel. +49 621 1703 4001, Fax +49 621 1703 4005, E-Mail firstname.lastname@example.org
Do you have an account?
Background: The Borderline Symptom List (BSL) was developed as a self-rating instrument to specifically quantify borderline-typical symptomatology. The items are based on the criteria of the DSM-IV, the Diagnostic Interview for Borderline Personality Disorder – revised version, the opinions of clinical experts and borderline patients. The psychometric properties and validity of the BSL have been investigated in several studies. Sampling and Methods: A total of 380 borderline patients and 204 healthy controls scored the items. A factor analysis of the BSL items suggests the following subscales: ‘self-perception’, ‘affect regulation’, ‘self-destruction’, ‘dysphoria’, ‘loneliness’, ‘intrusions’ and ‘hostility’. Results: Theinternal reliability as well as the test-retest reliability within 1 week are high. Different aspects of validity (e.g. comparison between groups) provide favorable results. Pre-post comparisons after 3 months of dialectical behavioral treatment reveal a significant reduction of the total score and of 5 of the 7 subscales. Conclusions: This indicates that the BSL is sensitive to therapeutically induced change of borderline-typical impairment.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.